Researchers Map Enhancer-Gene Interactions in Colorectal Cancer Using CRISPR Technology
Researchers used genome-wide CRISPRi Perturb-seq with over 35,000 guide RNAs to map functional relationships between distal DNA enhancers and their target genes in colorectal cancer, identifying 238 significant regulatory associations. The study integrated multiple genomic data types—chromatin accessibility, histone modification, and ultra-high-resolution chromatin conformation—to validate findings. The resulting map could help prioritize non-coding genetic variants as candidate cancer drivers in future sequencing studies.
A team of researchers deployed a genome-wide CRISPR interference (CRISPRi) Perturb-seq approach, using 35,139 guide RNAs targeting 12,117 enhancers, to systematically chart how distal regulatory elements control gene expression in colorectal cancer (CRC). The screen identified 238 statistically significant enhancer-gene regulatory associations at a false discovery rate below 10%. To validate and contextualize these findings, the researchers integrated chromatin accessibility data (ATAC-seq), histone modification profiling (ChIP-seq), and ultra-high-resolution chromatin conformation capture (Micro-C). A key finding was that enhancer regulation in CRC is largely constrained by topological domains—three-dimensional structural units of the genome—and that enhancers most commonly regulate the nearest gene rather than distant targets. These results were further supported by Activity-by-Contact computational modelling. The authors present the dataset as a foundational resource for studying gene regulation in colorectal tumorigenesis and for identifying non-coding genomic regions that may act as cancer drivers.
What's missing
The study was conducted in a colorectal cancer cell line context; it is unclear how well the enhancer-gene map generalizes to primary patient tumors or other CRC subtypes. The authors do not discuss the false negative rate of the screen, meaning some true enhancer-gene relationships may have been missed.
What different sources said
- bioRxivCenter
Enhancer-gene regulatory interactions in colorectal cancer revealed through genome-wide CRISPRi perturbations
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.